TMEM203
gene geneOn this page
Also known as MGC14327HBEBP1
Summary
TMEM203 (transmembrane protein 203, HGNC:28217) is a protein-coding gene on chromosome 9q34.3, encoding Transmembrane protein 203 (Q969S6). Involved in the regulation of cellular calcium homeotasis.
Involved in intracellular calcium ion homeostasis. Located in endoplasmic reticulum.
Source: NCBI Gene 94107 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 14 total — 1 pathogenic
- MANE Select transcript:
NM_053045
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:28217 |
| Approved symbol | TMEM203 |
| Name | transmembrane protein 203 |
| Location | 9q34.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | MGC14327, HBEBP1 |
| Ensembl gene | ENSG00000187713 |
| Ensembl biotype | protein_coding |
| OMIM | 616499 |
| Entrez | 94107 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000343666
RefSeq mRNA: 1 — MANE Select: NM_053045
NM_053045
CCDS: CCDS35185
Canonical transcript exons
ENST00000343666 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001374176 | 137204082 | 137205648 |
Expression profiles
Bgee: expression breadth ubiquitous, 134 present calls, max score 93.40.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 14.1709 / max 78.3085, expressed in 1803 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 103330 | 14.1709 | 1803 |
Top tissues by expression
134 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| apex of heart | UBERON:0002098 | 93.40 | gold quality |
| heart left ventricle | UBERON:0002084 | 92.69 | gold quality |
| gastrocnemius | UBERON:0001388 | 91.97 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 91.75 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 91.74 | gold quality |
| muscle of leg | UBERON:0001383 | 91.69 | gold quality |
| skin of leg | UBERON:0001511 | 91.50 | gold quality |
| heart | UBERON:0000948 | 91.39 | gold quality |
| prefrontal cortex | UBERON:0000451 | 91.35 | gold quality |
| zone of skin | UBERON:0000014 | 91.25 | gold quality |
| granulocyte | CL:0000094 | 91.17 | gold quality |
| skin of abdomen | UBERON:0001416 | 91.17 | gold quality |
| right lobe of liver | UBERON:0001114 | 91.10 | gold quality |
| frontal cortex | UBERON:0001870 | 91.06 | gold quality |
| right frontal lobe | UBERON:0002810 | 90.97 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 90.85 | gold quality |
| right atrium auricular region | UBERON:0006631 | 90.72 | gold quality |
| putamen | UBERON:0001874 | 90.70 | gold quality |
| cerebral cortex | UBERON:0000956 | 90.66 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 90.62 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 90.59 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 90.52 | gold quality |
| right adrenal gland | UBERON:0001233 | 90.42 | gold quality |
| nucleus accumbens | UBERON:0001882 | 90.40 | gold quality |
| fundus of stomach | UBERON:0001160 | 90.29 | gold quality |
| left adrenal gland | UBERON:0001234 | 90.20 | gold quality |
| caudate nucleus | UBERON:0001873 | 90.20 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 90.12 | gold quality |
| cortical plate | UBERON:0005343 | 90.08 | gold quality |
| lower esophagus | UBERON:0013473 | 89.93 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 2.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-7037 | yes | 82.39 |
| E-ANND-3 | yes | 5.84 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
24 targeting TMEM203, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3120-5P | 100.00 | 65.56 | 965 |
| HSA-MIR-6888-3P | 99.97 | 65.95 | 1170 |
| HSA-MIR-1321 | 99.84 | 65.30 | 1811 |
| HSA-MIR-4739 | 99.84 | 65.25 | 1832 |
| HSA-MIR-4756-5P | 99.84 | 64.98 | 1809 |
| HSA-MIR-6715A-3P | 99.83 | 68.05 | 1473 |
| HSA-MIR-6505-5P | 99.73 | 69.25 | 1595 |
| HSA-MIR-4328 | 99.57 | 71.06 | 4094 |
| HSA-MIR-543 | 99.52 | 69.03 | 2595 |
| HSA-MIR-330-3P | 99.41 | 69.95 | 2521 |
| HSA-MIR-6507-3P | 99.35 | 67.32 | 1059 |
| HSA-MIR-888-5P | 99.30 | 70.15 | 1855 |
| HSA-MIR-6715B-3P | 98.80 | 68.07 | 1204 |
| HSA-MIR-4463 | 98.56 | 66.05 | 1071 |
| HSA-MIR-7156-3P | 98.25 | 67.66 | 859 |
| HSA-MIR-891A-3P | 98.05 | 67.99 | 970 |
| HSA-MIR-506-5P | 98.02 | 67.41 | 1065 |
| HSA-MIR-7111-3P | 97.80 | 66.75 | 1467 |
| HSA-MIR-3194-5P | 96.80 | 64.90 | 1027 |
| HSA-MIR-597-3P | 96.46 | 68.03 | 1035 |
| HSA-MIR-3690 | 96.44 | 65.18 | 737 |
| HSA-MIR-635 | 96.00 | 65.54 | 687 |
| HSA-MIR-6774-5P | 95.94 | 65.18 | 722 |
| HSA-MIR-941 | 79.36 | 58.80 | 51 |
Literature-anchored findings (GeneRIF, showing 2)
- Tmem203 is an evolutionarily conserved regulator of cellular calcium homeostasis, is required for spermatogenesis and provides a causal link between intracellular calcium regulation and spermiogenesis. (PMID:25996873)
- Identification of TMEM203 sheds light into the control of STING-mediated innate immune responses. (PMID:31346090)
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | tmem203 | ENSDARG00000104996 |
| mus_musculus | Tmem203 | ENSMUSG00000078201 |
| rattus_norvegicus | Tmem203 | ENSRNOG00000072261 |
| drosophila_melanogaster | CG33932 | FBGN0066303 |
Protein
Protein identifiers
Transmembrane protein 203 — Q969S6 (reviewed: Q969S6)
All UniProt accessions (1): Q969S6
UniProt curated annotations — full annotation on UniProt →
Function. Involved in the regulation of cellular calcium homeotasis. Required for spermatogenesis. Acts as a regulator of STING-mediated inflammatory signaling in macrophages. Forms a complex with STING, promoting the activity of TBK1 kinase and the transcription factor IRF3, leading to activation of type I interferon expression.
Subunit / interactions. Homodimer. Interacts with ATP2A2, ITPR3 and STIM1. Interacts with STING1 (via transmembrane domain).
Subcellular location. Endoplasmic reticulum membrane. Endoplasmic reticulum-Golgi intermediate compartment. Lysosome membrane.
Tissue specificity. Increased expression seen in T-lymphocytes from patients with systemic lupus erythematosus (SLE).
RefSeq proteins (1): NP_444273* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR019396 | TM_Fragile-X-F-assoc | Family |
UniProt features (8 total): transmembrane region 4, region of interest 2, chain 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q969S6-F1 | 84.89 | 0.34 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 69 (showing top):
GOCC_VACUOLAR_MEMBRANE, GOBP_MALE_GAMETE_GENERATION, GOBP_MONOATOMIC_ION_HOMEOSTASIS, GOBP_DEVELOPMENTAL_PROCESS_INVOLVED_IN_REPRODUCTION, WHN_B, GOBP_HOMEOSTATIC_PROCESS, MARSON_BOUND_BY_FOXP3_UNSTIMULATED, GOBP_CHEMICAL_HOMEOSTASIS, GOCC_NUCLEAR_OUTER_MEMBRANE_ENDOPLASMIC_RETICULUM_MEMBRANE_NETWORK, GOCC_ENDOPLASMIC_RETICULUM_GOLGI_INTERMEDIATE_COMPARTMENT, GOCC_ORGANELLE_SUBCOMPARTMENT, NUYTTEN_NIPP1_TARGETS_DN, chr9q34, GSE13522_CTRL_VS_T_CRUZI_Y_STRAIN_INF_SKIN_IFNAR_KO_UP, GSE14415_NATURAL_TREG_VS_TCONV_UP
GO Biological Process (2): intracellular calcium ion homeostasis (GO:0006874), spermatogenesis (GO:0007283)
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (6): lysosomal membrane (GO:0005765), endoplasmic reticulum (GO:0005783), endoplasmic reticulum membrane (GO:0005789), endoplasmic reticulum-Golgi intermediate compartment (GO:0005793), lysosome (GO:0005764), membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cytoplasm | 2 |
| intracellular membrane-bounded organelle | 2 |
| intracellular monoatomic cation homeostasis | 1 |
| calcium ion homeostasis | 1 |
| developmental process involved in reproduction | 1 |
| male gamete generation | 1 |
| binding | 1 |
| lysosome | 1 |
| lytic vacuole membrane | 1 |
| endomembrane system | 1 |
| organelle membrane | 1 |
| nuclear outer membrane-endoplasmic reticulum membrane network | 1 |
| endoplasmic reticulum subcompartment | 1 |
| lytic vacuole | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
458 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| TMEM203 | SNX8 | Q9Y5X2 | 488 |
| TMEM203 | STIM1 | Q13586 | 392 |
| TMEM203 | ANKLE2 | Q86XL3 | 390 |
| TMEM203 | TMEM120A | Q9BXJ8 | 362 |
| TMEM203 | TMEM185B | Q9H7F4 | 360 |
| TMEM203 | SLC35G1 | Q2M3R5 | 349 |
| TMEM203 | TMEM60 | Q9H2L4 | 348 |
| TMEM203 | TRMT5 | Q32P41 | 347 |
| TMEM203 | FMC1 | Q96HJ9 | 347 |
| TMEM203 | SETD4 | Q9NVD3 | 347 |
| TMEM203 | ATG9A | Q7Z3C6 | 327 |
| TMEM203 | TMEM185A | Q8NFB2 | 321 |
| TMEM203 | CDPF1 | Q6NVV7 | 312 |
| TMEM203 | POP7 | O75817 | 309 |
| TMEM203 | SSR2 | P43308 | 307 |
| TMEM203 | NDOR1 | Q9UHB4 | 307 |
IntAct
113 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| TMEM203 | TMEM14B | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMEM203 | CPLX4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMEM203 | TMX2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMEM203 | RMDN3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMEM203 | TMEM234 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMEM203 | HSD17B13 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMEM203 | ATP6AP2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| STX4 | TMEM203 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMEM203 | CREB3L1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMEM203 | psi-mi:“MI:0915”(physical association) | 0.560 | |
| MFSD5 | TMEM203 | psi-mi:“MI:0915”(physical association) | 0.560 |
| LY6G6C | TMEM203 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CNR2 | TMEM203 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CPLX4 | TMEM203 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SSMEM1 | TMEM203 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ANK1 | TMEM203 | psi-mi:“MI:0915”(physical association) | 0.560 |
| FAM174A | TMEM203 | psi-mi:“MI:0915”(physical association) | 0.560 |
| STOM | TMEM203 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMEM203 | MANBAL | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMEM86B | TMEM203 | psi-mi:“MI:0915”(physical association) | 0.560 |
| RETREG3 | TMEM203 | psi-mi:“MI:0915”(physical association) | 0.560 |
| EBP | TMEM203 | psi-mi:“MI:0915”(physical association) | 0.560 |
BioGRID (44): TMEM203 (Two-hybrid), TMEM203 (Two-hybrid), TMEM203 (Two-hybrid), TMEM203 (Two-hybrid), TMEM203 (Two-hybrid), TMEM203 (Two-hybrid), TMEM203 (Two-hybrid), TMEM203 (Two-hybrid), TMEM203 (Two-hybrid), TMEM203 (Two-hybrid), TMEM203 (Two-hybrid), TMEM203 (Two-hybrid), TMEM203 (Two-hybrid), TMEM203 (Two-hybrid), TMEM203 (Two-hybrid)
ESM2 similar proteins: A2AF53, A4K2N5, A4K2W1, O75915, P51811, Q08DE2, Q1RMQ3, Q3SYY9, Q3ZBX1, Q49LS5, Q4R4R4, Q4R5E3, Q56P28, Q58DA4, Q58E26, Q5BJW3, Q5E9M1, Q5F3F5, Q5GH61, Q5PQQ4, Q5PR61, Q5R4X8, Q5R8H8, Q5R9W1, Q5ZI05, Q5ZII3, Q62302, Q68DH5, Q6AZ61, Q6P4P2, Q6UWH6, Q78S06, Q7SYC7, Q7ZUA6, Q8C561, Q8K0B2, Q8N2H4, Q8NFB2, Q8R235, Q8R3R5
Diamond homologs: Q5XH84, Q6GNX5, Q8R235, Q969S6
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
14 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 1 |
| Likely pathogenic | 0 |
| Uncertain significance | 13 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (1)
| Variant ID | HGVS | Classification |
|---|---|---|
| 2627632 | NM_001128228.3(TPRN):c.301G>T (p.Glu101Ter) | Pathogenic |
SpliceAI
303 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 9:137205142:CAGG:C | donor_gain | 0.8200 |
| 9:137205143:AGGA:A | donor_gain | 0.8200 |
| 9:137205599:AAC:A | donor_gain | 0.8000 |
| 9:137205034:CAG:C | acceptor_gain | 0.7300 |
| 9:137205037:C:CC | acceptor_gain | 0.7300 |
| 9:137205033:GCAG:G | acceptor_gain | 0.7100 |
| 9:137205034:CAGC:C | acceptor_gain | 0.7100 |
| 9:137205035:AG:A | acceptor_gain | 0.6900 |
| 9:137205600:A:C | donor_gain | 0.6700 |
| 9:137205194:T:TA | donor_gain | 0.6500 |
| 9:137205598:CA:C | donor_gain | 0.6500 |
| 9:137205599:AA:A | donor_gain | 0.6500 |
| 9:137205035:AGC:A | acceptor_loss | 0.6300 |
| 9:137205036:GCT:G | acceptor_loss | 0.6300 |
| 9:137205037:C:T | acceptor_loss | 0.6300 |
| 9:137205038:T:A | acceptor_loss | 0.6300 |
| 9:137205039:G:C | acceptor_loss | 0.6100 |
| 9:137204381:TTGG:T | acceptor_gain | 0.6000 |
| 9:137205047:A:C | acceptor_loss | 0.6000 |
| 9:137204688:T:C | donor_gain | 0.5900 |
| 9:137205272:TTCC:T | donor_gain | 0.5900 |
| 9:137205032:AGCAG:A | acceptor_gain | 0.5800 |
| 9:137205274:C:CT | donor_gain | 0.5300 |
| 9:137204687:A:AC | donor_gain | 0.5200 |
| 9:137205143:AGGAC:A | donor_gain | 0.5200 |
| 9:137205386:TG:T | donor_gain | 0.5200 |
| 9:137204600:T:A | donor_gain | 0.4900 |
| 9:137204777:A:C | acceptor_gain | 0.4900 |
| 9:137205135:TGAG:T | donor_gain | 0.4900 |
| 9:137205084:C:CA | donor_gain | 0.4800 |
AlphaMissense
867 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 9:137205139:A:C | S92R | 0.995 |
| 9:137205139:A:T | S92R | 0.995 |
| 9:137205141:T:G | S92R | 0.995 |
| 9:137205242:C:T | G58E | 0.983 |
| 9:137205384:A:G | W11R | 0.983 |
| 9:137205384:A:T | W11R | 0.983 |
| 9:137205049:G:C | F122L | 0.981 |
| 9:137205049:G:T | F122L | 0.981 |
| 9:137205051:A:G | F122L | 0.981 |
| 9:137205260:G:C | P52R | 0.980 |
| 9:137205056:G:C | P120R | 0.979 |
| 9:137205056:G:T | P120Q | 0.979 |
| 9:137205218:A:T | I66N | 0.979 |
| 9:137205235:G:C | S60R | 0.979 |
| 9:137205235:G:T | S60R | 0.979 |
| 9:137205237:T:G | S60R | 0.979 |
| 9:137205176:G:T | A80E | 0.971 |
| 9:137205137:A:T | L93H | 0.970 |
| 9:137205243:C:G | G58R | 0.970 |
| 9:137205243:C:T | G58R | 0.970 |
| 9:137205363:C:T | E18K | 0.968 |
| 9:137205072:C:G | G115R | 0.967 |
| 9:137205050:A:G | F122S | 0.966 |
| 9:137205047:A:T | I123N | 0.965 |
| 9:137205251:G:T | A55D | 0.964 |
| 9:137205260:G:T | P52H | 0.964 |
| 9:137205362:T:A | E18V | 0.964 |
| 9:137205207:G:T | R70S | 0.963 |
| 9:137205248:G:T | A56D | 0.963 |
| 9:137205253:G:C | F54L | 0.963 |
dbSNP variants (sampled 300 via entrez): RS1000316314 (9:137205948 G>A), RS1001913493 (9:137205120 T>C), RS1001986964 (9:137204743 T>A), RS1002966087 (9:137206627 C>A,T), RS1003091122 (9:137206889 G>A,T), RS1004095692 (9:137206362 G>A,T), RS1004339209 (9:137203888 G>A,C,T), RS1006128815 (9:137203853 T>C), RS1007013110 (9:137204934 GC>G), RS1007250234 (9:137205713 C>T), RS1007799023 (9:137206895 A>G), RS1008520183 (9:137204352 A>C,G), RS1009099395 (9:137207305 C>G,T), RS1009693603 (9:137204384 G>A,C), RS1010471773 (9:137205895 C>G,T)
Disease associations
OMIM: gene MIM:616499 | disease phenotypes: MIM:613307
GenCC curated gene-disease
Mondo (1): autosomal recessive nonsyndromic hearing loss 79 (MONDO:0013215)
Orphanet (1): Rare autosomal recessive non-syndromic sensorineural deafness type DFNB (Orphanet:90636)
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
MeSH disease descriptors (1)
| Descriptor | Name | Tree numbers |
|---|---|---|
| C567651 | Deafness, Autosomal Recessive 79 (supp.) |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
25 total (human), top 25 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| tris(1,3-dichloro-2-propyl)phosphate | decreases expression | 1 |
| sodium arsenite | decreases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| K 7174 | decreases expression | 1 |
| erucylphospho-N,N,N-trimethylpropylammonium | decreases expression | 1 |
| (4-amino-1,4-dihydro-3-(2-pyridyl)-5-thioxo-1,2,4-triazole)copper(II) | increases expression | 1 |
| Sunitinib | increases expression | 1 |
| Acetaminophen | increases expression | 1 |
| Air Pollutants | decreases expression, increases abundance | 1 |
| Atrazine | increases expression | 1 |
| Cadmium | increases abundance, increases expression | 1 |
| Doxorubicin | decreases expression | 1 |
| Estradiol | affects expression | 1 |
| Methyl Methanesulfonate | decreases expression | 1 |
| Silver | decreases expression | 1 |
| Thiram | decreases expression | 1 |
| Urethane | decreases expression | 1 |
| Valproic Acid | increases methylation | 1 |
| Cyclosporine | decreases expression | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
| Sodium Selenite | increases expression | 1 |
| Cadmium Chloride | increases abundance, increases expression | 1 |
| Copper Sulfate | decreases expression | 1 |
| Lactic Acid | decreases expression | 1 |
| Particulate Matter | decreases expression, increases abundance | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): autosomal recessive nonsyndromic hearing loss 79